Investment
Features
FeesSafety
Academy
More
Pluang+

FT Vest S&P 500 Dividend Aristocrats ETF downgraded to hold on weak valuation and tech underweight.

Market News
17 Sep 2026
Seeking Alpha
View Source
Bearish
FT Vest S&P 500 Dividend Aristocrats ETF downgraded to hold on weak valuation and tech underweight.

The FT Vest S&P 500 Dividend Aristocrats Target Income ETF (KNG) was downgraded to a hold rating due to its lackluster valuation and technical indicators. Despite offering a high yield of 8.5% through a buy-write strategy, KNG has underperformed both the S&P 500 and the NOBL ETF. Its portfolio is heavily weighted in Consumer Staples and underweighted in Information Technology, causing it to lag in the current tech-driven market. Although seasonal trends improve in November, KNG’s sideways price movement and flat 200-day moving average support a neutral investment stance for now.

The FT Vest S&P 500 Dividend Aristocrats Target Income ETF (KNG) is noted alongside Pluang's market data as of Sep 18, 2026 02:21 WIB. For readers following US stocks, here is Pluang's market snapshot: out of 150 priced US stocks, 106 rose and 44 fell today. Notable movers include AMD at USD 546.28 with a 1-day change of +6.59% and Pluang order activity showing 77% Sell / 23% Buy, SPCE at USD 3.12 with a 1-day change of +6.48% and balanced order activity, and PLUG at USD 2.15 with a 1-day change of +6.19% and 42% Sell / 58% Buy activity.

More News

Jefferies keeps Kinder Morgan on Hold, lowers price target to $33 amid stable cash flows and growth.

Jefferies keeps Kinder Morgan on Hold, lowers price target to $33 amid stable cash flows and growth.

Jefferies maintained a Hold rating on Kinder Morgan, lowering its price target from $35 to $33, which remains above the current stock price of $31.31. The company benefits from stable cash flows, with 96% secured by fee-based or hedged contracts, inc...

Analyst Insights
Neutral
18 minutes ago
Stocks surge on patent wins, financing deals, and merger announcements.

Stocks surge on patent wins, financing deals, and merger announcements.

Several stocks saw sharp gains driven by key company developments. bioAffinity Technologies surged 63.55% after securing a Hong Kong patent for its lung cancer diagnostic technology, boosting its Asian market position. Antelope Enterprise Holdings ro...

Market News
Bullish
27 minutes ago
KB Home Q3 earnings expected to drop sharply, with revenue and EPS forecast down significantly.

KB Home Q3 earnings expected to drop sharply, with revenue and EPS forecast down significantly.

KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has rec...

Company Fundamentals
Bearish
1 hour ago
$10,000 invested in Nebius in 2024 is now worth about $105,000 in 2026

$10,000 invested in Nebius in 2024 is now worth about $105,000 in 2026

An investment of $10,000 in Nebius when it resumed trading in 2024 has grown significantly to approximately $105,000 by 2026. This remarkable increase highlights Nebius's strong market performance over the two-year period. Investors who bought in at ...

Market News
Bullish
2 hours ago
W.P. Carey projects $1.9B investment in 2026 with strong tenant outlook and institutional support.

W.P. Carey projects $1.9B investment in 2026 with strong tenant outlook and institutional support.

W.P. Carey expects to invest over $1.9 billion in 2026, reflecting robust growth in its net lease property portfolio. Despite a slight reduction in its price target by Scotiabank to $76, the stock still shows potential upside from current levels. The...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App